Clinical Trials Insight: 700009427
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2007
At a glance
- Drugs ANA 975 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Anadys Pharmaceuticals
- 01 Nov 2007 Status changed from suspended to discontinued.
- 29 Nov 2005 New trial record.